Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04646473 · ClinicalTrials.gov registry record · NA

Sweetgoals for Type 1 Diabetes

A NA study of Type 1 Diabetes, sponsored by Trustees of Dartmouth College.

Completed
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT04646473 is a NA study of Type 1 Diabetes that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 300 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04646473, a NA study of Type 1 Diabetes, has completed, sponsored by Trustees of Dartmouth College.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The study will test an app and web-delivered intervention designed to improve glycemic control (HbA1c) among young adults with Type 1 diabetes. All participants will receive the "core" digital intervention, the SweetGoals app, focused on self-monitoring and goal setting. Efficacy of two independent intervention components (incentives for adherence and web health coaching) will be tested

Conditions Studied

Interventions

  • BEHAVIORAL Incentives
  • BEHAVIORAL SweetGoals app
  • BEHAVIORAL Coaching

Study Locations (1)

New Hampshire

  • Dartmouth College - Hanover

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2021-04-29
Est. Completion 2025-04-30
Phase NA

Sponsor

Trustees of Dartmouth College

31 total trials

What the Registry Record Tells You About NCT04646473

The ClinicalTrials.gov registry entry for NCT04646473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (64% lower). The listed sponsor is Trustees of Dartmouth College, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Incentives is the first listed.

NCT04646473 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT04646473 about?

NCT04646473 is a clinical study titled "Sweetgoals for Type 1 Diabetes". The study will test an app and web-delivered intervention designed to improve glycemic control (HbA1c) among young adults with Type 1 diabetes. All participants will receive the "core" digital intervention, the SweetGoals app, focused on self-monitoring and goal setting. Efficacy of two independent ...

What is the current status of trial NCT04646473?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2021-04-29. Estimated completion is 2025-04-30.

What conditions does trial NCT04646473 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT04646473?

The interventions under investigation include: Incentives (BEHAVIORAL), SweetGoals app (BEHAVIORAL), Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT04646473?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04646473 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.